Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02044718
Other study ID # 11.50/intens11.01
Secondary ID
Status Completed
Phase N/A
First received December 19, 2013
Last updated January 22, 2014
Start date November 2011
Est. completion date June 2013

Study information

Verified date January 2014
Source Hasselt University
Contact n/a
Is FDA regulated No
Health authority Belgium: Institutional Review Board
Study type Observational

Clinical Trial Summary

An adverse event (AE) is defined as unintended injury or complication, which results in disability, death or prolongation of hospital stay, and is caused by healthcare management (including omissions) rather than the patient's disease. Retrospective record reviews in several countries have shown that 2,9% to 16,6% of patients in acute hospitals experience one or more AEs. A patient with an AE may require a higher level of care. Although all AEs are important, preventable AEs that result in an upgraded level of patient care are of particular concern. In this study it's defined as an unplanned admission to intensive care unit (ICU) or a Mobile Emergency Team (MET) intervention. The objectives of this study are to determine the incidence of (preventable) adverse events requiring ICU admission or MET intervention and to assess the level of harm of each AE.


Recruitment information / eligibility

Status Completed
Enrollment 878
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group 16 Years and older
Eligibility Inclusion Criteria:

- All patients being transferred to a higher level of care during the study period (November 2011 - May 2012)

- In practice, the higher level of care means

- (1) (re)admission to the Intensive Care Unit from other care units in the hospital providing lower intensity care,

- (2) to an intervention by a Medical Emergency Team due to an unanticipated change in the patient's clinical status

Exclusion Criteria:

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms

  • Lung Diseases
  • Myocardial Infarction
  • Sepsis, Cancer, Heart Attack, Heart Failure, Abdominal Surgery, Trauma, Diabetes, Lung Disease, Gynaecology, Fertility, Cardiac Surgery,

Locations

Country Name City State
Belgium Hasselt University Hasselt Limburg

Sponsors (7)

Lead Sponsor Collaborator
Hasselt University Algemeen Ziekenhuis Vesalius, Jessa Hospital, Regionaal Ziekenhuis Sint-Trudo, Sint-Franciscus Ziekenhuis, Ziekenhuis Maas en Kempen, Ziekenhuis Oost-Limburg

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of adverse events requiring a higher level of care An adverse event is an unintended injury or complication, which results in disability at discharge, death or prolongation of hospital stay, and is caused by healthcare management (including omissions) rather than the patient's disease. (Wilson, 1995) 6 months Yes
Primary The number of participants with preventable adverse events Assess the preventability of these adverse events using six point scale with a range of not preventable until totally preventable 6 months Yes
Secondary Type adverse events Divide the adverse events into categories, like diagnosis, therapy, medication, surgery, non-surgery, etc. 6 months Yes
Secondary Clinical impact of adverse events in terms of outcome Assess the impact of the adverse events in terms of disability, mortality, readmission. 6 months Yes
Secondary Quality of the chart review The patient chart will be judge on the completeness and adequacy 6 months Yes